Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

3 Comeback Stories You Shouldn’t Bet On

Investors looking for a comeback would be wise to avoid GPRO, SPLS and FIT. All three have promised good things but remain stocks to avoid.

4 Food Products Stocks to Sell Now

This week, the ratings of 4 Food Products stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

8 Health Care Providers & Services Stocks to Sell Now

This week, 8 Health Care Providers & Services stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Trading Companies & Distributors Stocks to Sell Now

The ratings of 4 Trading Companies & Distributors stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Thrifts & Mortgage Finance Stocks to Sell Now

This week, the overall grades of 3 Thrifts & Mortgage Finance stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Poor Earnings Growth — BBRY EMG SEV STFC SPWR

This week, these five stocks have the worst ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

Valeant Pharmaceuticals Intl Inc (VRX) Just Doesn’t Get it

Valeant Pharmaceuticals (VRX) CEO Joe Papa may be an experienced pharmaceutical industry veteran, but he still has at least one lesson to learn the hard way.

3 Metals & Mining Stocks to Sell Now

The ratings of 3 Metals & Mining stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Media Stocks to Sell Now

This week, the overall grades of 3 Media stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

26 Biotechnology Stocks to Sell Now

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

11 Health Care Equipment & Supplies Stocks to Sell Now

The overall ratings of 11 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 IT Services Stocks to Sell Now

The ratings of 6 IT Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Airlines Stocks to Sell Now

This week, the overall grades of 4 Airlines stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

5 Stocks With Poor Operating Margin — KONE SPLS CCCL EPE ENLC

This week, these five stocks have the worst ratings in Operating Margin, one of the eight Fundamental Categories on Portfolio Grader.

Intel Corporation (INTC) Stock Has Already Topped Out

Intel (INTC) hit a 15-year high Friday, but the reasons for this Intel stock rally won't last and should have been priced in.

VimpelCom Ltd (ADR) (VIP) Forfeits Gains on Secondary Offering

VIP stock is being taken to the woodshed on intense volume after pricing a secondary offering of VimpelCom shares.

Deutsche Bank AG (USA) (DB) Is a Disaster of a Stock

The DoJ's aggressive posture on negotiation a settlement with Deutsche Bank (DB) will kneecap DB stock for some time. Investors need not apply.

5 Household Durables Stocks to Sell Now

This week, the ratings of 5 Household Durables stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

14 Pharmaceuticals Stocks to Sell Now

The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").